Novozymes A/S (OTCMKTS:NVZMY) Shares Gap Up – What’s Next?

Shares of Novozymes A/S (OTCMKTS:NVZMY) gapped up before the market opened on Wednesday . The stock had previously closed at $59.62, but opened at $62.25. Novozymes A/S shares last traded at $62.2355, with a volume of 934 shares changing hands.

Wall Street Analyst Weigh In

NVZMY has been the topic of a number of research reports. Kepler Capital Markets upgraded Novozymes A/S from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Zacks Research raised Novozymes A/S from a “strong sell” rating to a “hold” rating in a report on Monday, June 8th. Finally, Rothschild & Co Redburn upgraded Novozymes A/S to a “strong-buy” rating in a research report on Friday, March 27th. Two analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy”.

Novozymes A/S Price Performance

The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.03 and a current ratio of 1.67. The company’s fifty day simple moving average is $59.32 and its two-hundred day simple moving average is $60.27. The stock has a market capitalization of $25.65 billion, a PE ratio of 41.80, a P/E/G ratio of 1.18 and a beta of 0.95.

Novozymes A/S (OTCMKTS:NVZMY) last announced its quarterly earnings results on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.31). The business had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. Novozymes A/S had a net margin of 14.22% and a return on equity of 6.52%. As a group, sell-side analysts predict that Novozymes A/S will post 2.43 EPS for the current year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).